載入...
Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience
BACKGROUND: Persistent significant proteinuria has been associated with increased risk of progression to end-stage kidney disease in patients with idiopathic membranous nephropathy (IMN). Rituximab (RTX) therapy has given encouraging results in IMN, but most of the studies have used a higher dose, w...
Na minha lista:
| 發表在: | Clin Kidney J |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6007352/ https://ncbi.nlm.nih.gov/pubmed/29942496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfx105 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|